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background: Severely symptomatic patients with obstructive HCM may benefit from surgical myectomy. Previous studies have demonstrated that 
elongation of the anterior mitral valve leaflet may result in suboptimal outcome after myectomy. The aim of this study was to evaluate the long-term 
results of myectomy combined with anterior mitral leaflet extension (MLE) in patients with obstructive HCM
Methods: This prospective observational single-center cohort study included 98 patients (49 ±14 years, 37% female) who underwent myectomy 
combined with MLE between 1991 - 2012. Endpoints included all-cause mortality, and change in clinical and echocardiographic characteristics. 
Mortality was compared with age-and gender matched non-obstructive HCM patients and subjects from the general population.
results: Long-term follow-up was 8.3 ±6.1 years. There was no operative mortality and NYHA class was reduced from 2.8 ±0.5 to 1.3 ±0.5 
(p<0.001); left ventricular outflow tract gradient from 93 ±25 to 9 ±8 mmHg (p<0.001); mitral valve regurgitation from grade 2.0 ±0.9 to 0.5 ±0.8 
(p<0.001); and systolic anterior motion of the mitral valve from grade 2.4 ±0.9 to 0.1 ±0.3 (p<0.001). The 5-, 10-, and 15-year cumulative survival 
was 92%, 86%, and 83%; and did not differ from the general population (p=0.3) or non-obstructive HCM patients (p=0.8, Figure 1).
conclusions: In selected obstructive HCM patients myectomy combined with MLE is safe and results in long-term symptom relief and survival 
similar to general population.
 
